AU Stock MarketDetailed Quotes

NSB Neuroscientific Biopharmaceuticals Ltd

Watchlist
  • 0.036
  • 0.0000.00%
20min DelayMarket Closed Nov 14 13:54 AET
5.21MMarket Cap18.00P/E (Static)

Neuroscientific Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
Cost of revenue
Gross profit
Operating expense
-66.42%2.06M
-41.69%6.12M
148.69%10.5M
43.59%4.22M
65.41%2.94M
1.78M
Selling and administrative expenses
-27.15%1.29M
-35.40%1.77M
73.58%2.73M
36.66%1.57M
96.96%1.15M
--584.95K
-General and administrative expense
-27.15%1.29M
-35.40%1.77M
73.58%2.73M
36.66%1.57M
96.96%1.15M
--584.95K
Research and development costs
-87.77%492.46K
-44.24%4.03M
225.53%7.22M
55.89%2.22M
94.78%1.42M
--730.42K
Depreciation amortization depletion
57.87%91.34K
-10.88%57.85K
5.71%64.92K
8.38%61.41K
2.64%56.66K
--55.21K
-Depreciation and amortization
57.87%91.34K
-10.88%57.85K
5.71%64.92K
8.38%61.41K
2.64%56.66K
--55.21K
Other operating expenses
-32.14%186.54K
-43.41%274.87K
31.35%485.73K
19.32%369.79K
-23.97%309.91K
--407.63K
Operating profit
66.42%-2.06M
41.69%-6.12M
-148.69%-10.5M
-43.59%-4.22M
-65.41%-2.94M
-1.78M
Net non-operating interest income (expenses)
64.35%168.94K
50.18%102.8K
148.17%68.45K
-14.65%27.58K
-62.18%32.32K
85.44K
Non-operating interest income
66.41%178.94K
57.09%107.53K
147.60%68.45K
-22.63%27.65K
-58.18%35.73K
--85.44K
Non-operating interest expense
111.17%10K
--4.73K
----
-98.16%63
--3.42K
----
Other net income (expenses)
-55.34%2.21M
4.95M
2,411.67%1.02M
19.77%40.54K
33.85K
Other non-operating income (expenses)
-55.34%2.21M
--4.95M
----
2,411.67%1.02M
19.77%40.54K
--33.85K
Income before tax
130.34%324.21K
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Income tax
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
130.34%324.21K
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Net income continuous operations
130.34%324.21K
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
---1.66M
Noncontrolling interests
Net income attributable to the company
130.34%324.21K
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
130.34%324.21K
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Diluted earnings per share
129.73%0.0022
89.82%-0.0074
-227.48%-0.0727
39.51%-0.0222
-58.19%-0.0367
-0.0232
Basic earnings per share
129.73%0.0022
89.82%-0.0074
-227.48%-0.0727
39.51%-0.0222
-58.19%-0.0367
-0.0232
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue
Cost of revenue
Gross profit
Operating expense -66.42%2.06M-41.69%6.12M148.69%10.5M43.59%4.22M65.41%2.94M1.78M
Selling and administrative expenses -27.15%1.29M-35.40%1.77M73.58%2.73M36.66%1.57M96.96%1.15M--584.95K
-General and administrative expense -27.15%1.29M-35.40%1.77M73.58%2.73M36.66%1.57M96.96%1.15M--584.95K
Research and development costs -87.77%492.46K-44.24%4.03M225.53%7.22M55.89%2.22M94.78%1.42M--730.42K
Depreciation amortization depletion 57.87%91.34K-10.88%57.85K5.71%64.92K8.38%61.41K2.64%56.66K--55.21K
-Depreciation and amortization 57.87%91.34K-10.88%57.85K5.71%64.92K8.38%61.41K2.64%56.66K--55.21K
Other operating expenses -32.14%186.54K-43.41%274.87K31.35%485.73K19.32%369.79K-23.97%309.91K--407.63K
Operating profit 66.42%-2.06M41.69%-6.12M-148.69%-10.5M-43.59%-4.22M-65.41%-2.94M-1.78M
Net non-operating interest income (expenses) 64.35%168.94K50.18%102.8K148.17%68.45K-14.65%27.58K-62.18%32.32K85.44K
Non-operating interest income 66.41%178.94K57.09%107.53K147.60%68.45K-22.63%27.65K-58.18%35.73K--85.44K
Non-operating interest expense 111.17%10K--4.73K-----98.16%63--3.42K----
Other net income (expenses) -55.34%2.21M4.95M2,411.67%1.02M19.77%40.54K33.85K
Other non-operating income (expenses) -55.34%2.21M--4.95M----2,411.67%1.02M19.77%40.54K--33.85K
Income before tax 130.34%324.21K89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Income tax 000000
Earnings from equity interest net of tax
Net income 130.34%324.21K89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Net income continuous operations 130.34%324.21K89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M---1.66M
Noncontrolling interests
Net income attributable to the company 130.34%324.21K89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 130.34%324.21K89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Diluted earnings per share 129.73%0.002289.82%-0.0074-227.48%-0.072739.51%-0.0222-58.19%-0.0367-0.0232
Basic earnings per share 129.73%0.002289.82%-0.0074-227.48%-0.072739.51%-0.0222-58.19%-0.0367-0.0232
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data